Literature DB >> 16847929

Rituximab in a child with relapsed Burkitt lymphoma.

Ali Bay, Murat Dogan, Mehmet Acikgoz, Ahmet Faik Oner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 16847929     DOI： 10.1002/pbc.20957

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  3 in total

1.  Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.

Authors:  Anne Jourdain; Anne Auperin; Véronique Minard-Colin; Nathalie Aladjidi; Josef Zsiros; Carole Coze; Virginie Gandemer; Yves Bertrand; Guy Leverger; Christophe Bergeron; Jean Michon; Catherine Patte
Journal:  Haematologica       Date:  2015-02-27       Impact factor: 9.941

2.  Use of rituximab in three children with relapsed/refractory Burkitt lymphoma.

Authors:  Sinan Akbayram; Murat Doğan; Cihangir Akgün; Fatih Erbey; Hüseyin Caksen; Ahmet Faik Oner
Journal:  Target Oncol       Date:  2010-09-22       Impact factor: 4.493

3.  Rituximab used in three cases with relapsed non-Hodgkin's lymphoma.

Authors:  Murat Elli; Sema Yilmaz; Ramazan Aydin; Sadriye Murat; Meltem Ceyhan Bilgici; Ayhan Dagdemir
Journal:  Mol Clin Oncol       Date:  2013-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.